Purpose of Review: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that affects nearly 1 million people in the USA and has the potential to profoundly affect physical ability and income potential at a young age. Since a landmark paper was published in 2014, few studies have looked at differences in MS disease characteristics between African-American and Caucasian patients. Recent Findings: African-American patients often have a more severe MS disease course, as well as biomarker data which can portend a worse prognosis. While the sample sizes are usually quite small, subgroup analyses of African-American patients have been performed to evaluate efficacy of disease-modifying treatments as compared with the entire study population, made up of primarily Caucasians. Summary: In an era where we strive for personalized medicine, understanding racial differences in MS may help us better treat African-American patients in the future.
CITATION STYLE
Cipriani, V. P., & Klein, S. (2019, November 1). Clinical Characteristics of Multiple Sclerosis in African-Americans. Current Neurology and Neuroscience Reports. Current Medicine Group LLC 1. https://doi.org/10.1007/s11910-019-1000-5
Mendeley helps you to discover research relevant for your work.